Is Casualty Medical Systems Incorporated (NASDAQ:CASM) a Buy? The Stock Reported more Sellers

September 17, 2017 - By test

 Is Casualty Medical Systems Incorporated (NASDAQ:CASM) a Buy? The Stock Reported more Sellers

Investors sentiment increased to 1.6 in 2016 Q4. Its up 1.04, from 0.56 in 2016Q3. It is positive, as 2 investors sold CAS Medical Systems Inc shares while 3 reduced holdings. 4 funds opened positions while 4 raised stakes. 8.61 million shares or 2.79% less from 8.85 million shares in 2016Q3 were reported.
Hightower Advisors Lc has invested 0% of its portfolio in CAS Medical Systems Inc (NASDAQ:CASM). Blackrock Invest Mngmt Ltd Liability Com invested 0% of its portfolio in CAS Medical Systems Inc (NASDAQ:CASM). California Public Employees Retirement Systems holds 10,400 shares. Wells Fargo And Com Mn stated it has 2,227 shares. Guggenheim Ltd Company stated it has 12,517 shares. Td Cap Mgmt Lc reported 29,429 shares stake. Deerfield Management Company stated it has 0.21% in CAS Medical Systems Inc (NASDAQ:CASM). Moreover, Panagora Asset has 0% invested in CAS Medical Systems Inc (NASDAQ:CASM) for 22,298 shares. Citadel Advisors Ltd Limited Liability Company invested in 18,595 shares or 0% of the stock. Blackrock Fund owns 0% invested in CAS Medical Systems Inc (NASDAQ:CASM) for 99,872 shares. Susquehanna Intl Group Inc Limited Liability Partnership owns 22,851 shares. Deutsche Natl Bank Ag reported 0% of its portfolio in CAS Medical Systems Inc (NASDAQ:CASM). Acuta Capital Prtnrs Ltd owns 4.18 million shares or 2.5% of their US portfolio. Vanguard Group Inc owns 514,132 shares or 0% of their US portfolio. Morgan Stanley owns 200 shares.

The stock of Casualty Medical Systems Incorporated (NASDAQ:CASM) registered an increase of 38.98% in short interest. CASM’s total short interest was 217,500 shares in September as published by FINRA. Its up 38.98% from 156,500 shares, reported previously. With 20,600 shares average volume, it will take short sellers 11 days to cover their CASM’s short positions. The short interest to Casualty Medical Systems Incorporated’s float is 1.11%.

The stock increased 1.14% or $0.01 on September 15, reaching $0.89. About 15,110 shares traded. CAS Medical Systems Inc (NASDAQ:CASM) has declined 47.56% since September 17, 2016 and is downtrending. It has underperformed by 64.26% the S&P500.

CAS Medical Systems, Inc. is a medical technology firm that develops, makes and markets non-invasive patient monitoring products for patient care. The company has market cap of $25.13 million. The Firm designs, makes and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It currently has negative earnings. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.

More important recent CAS Medical Systems Inc (NASDAQ:CASM) news were published by: Seekingalpha.com which released: “CAS Medical Systems: Double-Digit Top-line Organic Growth, Recurring Revenue …” on February 14, 2017, also Seekingalpha.com published article titled: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q4 2016 Results – Earnings Call …”, Seekingalpha.com published: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q1 2017 Results – Earnings Call …” on May 03, 2017. More interesting news about CAS Medical Systems Inc (NASDAQ:CASM) was released by: Globenewswire.com and their article: “CASMED to Report Third-Quarter 2016 Financial Results and Hold Conference Call …” with publication date: November 02, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.